Europe Custom Antibody Market
Customized antibodies can be generated in a mouse, rat, or hamster, to meet any host requirements. Companies are providing a wide range of antibodies according to the researcher's requirements. There are various customized antibodies in the market, including polyclonal and monoclonal antibodies, recombinant monoclonal antibodies, hybridoma antibodies, polyclonal recombinant antibodies, etc. In addition, companies offer complete support services for all types and steps of antibody production from peptide design, synthesis, and carrier protein conjugation to animal immunization, serum collection, or hybridoma fusion, titre analysis, and final antibody purification.
Thus, the high demand in research is expected to create a significant demand for custom antibody in the coming years, which is further anticipated to drive the custom antibody market.
Countries in the European regions were profoundly affected due to the COVID-19 pandemic. For instance, countries such as Italy, Spain, and France have reported the highest number of positive cases and have registered the maximum number of deaths. Several companies have experienced severe losses in the last quarter of 2019; they have also negatively influenced the first and second quarters of 2020. Hence, the impact of COVID 19 on the European market was immediate and drastic. The custom antibody supply chain, which is already logistically complicated, has to face new challenges. The custom antibody market has also witnessed some shortfall at the beginning of the COVID 19 crisis due to disruption in supply chain and demand due to lockdown announced by most European countries. This result may last till the end of 2020 as most of the market players in Europe yet to adopt the novel diagnostic tests for COVID 19. However, in the extended period, the requirement for custom antibodies is expected to increase due to supportive government initiatives. For instance, in May 2020, ProteoGenix launched the first Human Immune COVID-19 library for the fast development of potent antibodies against SARS-CoV-2. Hence, the European custom antibody market will likely show significant growth prospects during this pandemic and forecasted year. Therefore, the preference for adopting custom antibody provides a favorable environment for the growth of the Europe custom antibody market during the forecast period.
Strategic insights for the Europe Custom Antibody provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 102.5 Million |
| Market Size by 2028 | US$ 213.7 Million |
| Global CAGR (2021 - 2028) | 11.1% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By Service
|
| Regions and Countries Covered | Europe
|
| Market leaders and key company profiles |
The geographic scope of the Europe Custom Antibody refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.
The Custom antibody market in Europe is expected to grow from US$ 102.5 million in 2021 to US$ 213.7 million by 2028; it is estimated to grow at a CAGR of 11.1% from 2021 to 2028. Antibodies, including monoclonal and polyclonal, find applications in academic, research, and pharmaceutical institutes and organizations. Using these antibodies, institutes and organizations conduct several research and development activities for drug and biomarker developments, and other therapeutic and clinical diagnostics product developments. Custom antibodies are widely preferred in research to differentiate the antibody products. These antibodies are continuously evaluated to provide safe, accurate, and efficient products with improved quality. Small and medium-sized companies have increased their research and development investments and activities exponentially. Such investments have escalated the demand for custom antibodies.
In terms of service, the antibody development segment accounted for the largest share of the Europe custom antibody market in 2020. In terms of type, the monoclonal antibodies segment accounted for the largest share of the Europe custom antibody market in 2020. In terms of source, the mice segment accounted for the largest share of the Europe custom antibody market in 2020. In terms of research area, the oncology segment held a larger market share of the custom antibody market in 2020. In terms of end user, the pharmaceutical and biotechnology companies segment held a larger market share of the custom antibody market in 2020.
A few major primary and secondary sources referred to for preparing this report on the custom antibody market in Europe are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., Merck KGAA, Abcam, Genscript, Agilent Technologies, Inc., and Cell Signaling Technology, Inc.
By Service
By Type
By Source
By Research Area
By End User
By Country
The Europe Custom Antibody Market is valued at US$ 102.5 Million in 2021, it is projected to reach US$ 213.7 Million by 2028.
As per our report Europe Custom Antibody Market, the market size is valued at US$ 102.5 Million in 2021, projecting it to reach US$ 213.7 Million by 2028. This translates to a CAGR of approximately 11.1% during the forecast period.
The Europe Custom Antibody Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Custom Antibody Market report:
The Europe Custom Antibody Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Europe Custom Antibody Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Europe Custom Antibody Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Europe Custom Antibody Market
